FIELD: medicine, pharmaceutics. SUBSTANCE: preparation is manufactured based upon adenosine-5'-triphosphate in isotonic solution. As a source of adenosine-5'- triphosphate the preparation contains tripotassium salt of adenosine-5'-triphosphatohistidineatomagnesium (II) octahydrate at 10-20 g amount/1000 ml isotonic solution. It additionally contains a pharmaceutically acceptable organic or inorganic acid or its acid salt at the quantity necessary to achieve pH= 7.0-7.4. It preferably contains citric acid at 0.6-1.2/1000 ml isotonic solution. EFFECT: higher curative-prophylactic action and prolonged storage terms. 1 cl, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
POTASSIUM SALTS OF DIFFERENT-LIGAND COORDINATION COMPOUNDS OF MAGNESIUM WITH HISTIDINE, ADENOSINE-5'-TRIPHOSPHATE AND CREATINE PHOSPHATE SHOWING PROTECTIVE EFFECT ON MYOCARDIUM AGAINST ISCHEMIC DAMAGE | 1997 |
|
RU2144922C1 |
β-HYDROXY ETHYLAMINIUM NICOTINATE DERIVATIVES HAVING ANTIISCHENIC ACTIVITY | 1993 |
|
RU2124502C1 |
UBIQUINOL COMPOSITION FOR PARENTERAL ADMINISTRATION AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2635993C1 |
ANTIINFLAMMATORY AGENT | 1994 |
|
RU2118161C1 |
NITROGLYCEROL AQUEOUS SOLUTION FOR INFUSION AND A METHOD OF ITS PREPARING | 1993 |
|
RU2092158C1 |
METHOD FOR PRODUCTION OF ANTICORROSION PIGMENT ON BASE OF ALUMINIUM TRIPHOSPHATE | 1995 |
|
RU2102420C1 |
ANTIISCHEMICALLY-ACTIVE AGENT | 1988 |
|
RU2007985C1 |
MEDICINAL PREPARATION FOR CURING CEREBRAL ISCHEMIA | 1994 |
|
RU2108095C1 |
INJECTION FORM OF PHARMACEUTICAL COMPOSITION (VERSIONS) FOR PREVENTING AND TREATING NEUROPATHIES AND METHOD FOR PREPARING IT | 2010 |
|
RU2448706C2 |
METHOD OF THE CONCENTRATED BIFIDUMBACTERIN PREPARING | 1993 |
|
RU2072856C1 |
Authors
Dates
2002-10-10—Published
1999-03-18—Filed